Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2017

Open Access 01-12-2017 | Case report

Upper lip metastasis of sarcomatoid carcinoma of the lung – an unusual site of disease: a case report

Authors: Tri Le, Melissa Mayer, Joseph Sailors, David E. Gerber, John M. Truelson

Published in: Journal of Medical Case Reports | Issue 1/2017

Login to get access

Abstract

Background

Lip metastases are rare clinical events that are frequently mistaken for other diagnoses. For sarcomatoid lung carcinoma, a rare histologic variant of non-small cell lung cancer, the incidence and pattern of cutaneous spread is poorly understood.

Case presentation

We present a case of a 79-year-old African American man with a rapidly progressive upper lip cutaneous lesion that provided the first evidence of distant metastatic spread of sarcomatoid lung carcinoma.

Conclusions

This is the first reported case of lip metastasis in sarcomatoid lung carcinoma. It highlights the importance of maintaining a high level of suspicion for metastatic disease in the presence of new cutaneous findings as they may be the first evidence of advanced disease.
Literature
1.
go back to reference Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. World Health Organization Classification of Tumours. Pathology and genetics of tumors of the lung, pleura, thymus, and heart. Lyon: IARC Press; 2004. p. 53–8. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. World Health Organization Classification of Tumours. Pathology and genetics of tumors of the lung, pleura, thymus, and heart. Lyon: IARC Press; 2004. p. 53–8.
2.
go back to reference Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol. 2015;10(9):1243–60.CrossRefPubMed Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol. 2015;10(9):1243–60.CrossRefPubMed
3.
go back to reference Martin LW, Correa AM, Ordonez NG, et al. Sarcomatoid carcinoma of the lung: a predictor of poor prognosis. Ann Thorac Surg. 2007;84(3):973–80.CrossRefPubMed Martin LW, Correa AM, Ordonez NG, et al. Sarcomatoid carcinoma of the lung: a predictor of poor prognosis. Ann Thorac Surg. 2007;84(3):973–80.CrossRefPubMed
4.
go back to reference Venissac N, Pop D, Lassalle S, Berthier F, Hofman P, Mouroux J. Sarcomatoid lung cancer (spindle/giant cells): an aggressive disease? J Thorac Cardiovasc Surg. 2007;134(3):619–23.CrossRefPubMed Venissac N, Pop D, Lassalle S, Berthier F, Hofman P, Mouroux J. Sarcomatoid lung cancer (spindle/giant cells): an aggressive disease? J Thorac Cardiovasc Surg. 2007;134(3):619–23.CrossRefPubMed
5.
go back to reference Italiano A, Cortot AB, Ilie M, et al. EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: implications for anti-EGFR treatment of a rare lung malignancy. Int J Cancer. 2009;125(10):2479–82.CrossRefPubMed Italiano A, Cortot AB, Ilie M, et al. EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: implications for anti-EGFR treatment of a rare lung malignancy. Int J Cancer. 2009;125(10):2479–82.CrossRefPubMed
6.
go back to reference Jiang X, Liu Y, Chen C, et al. The value of biomarkers in patients with sarcomatoid carcinoma of the lung: molecular analysis of 33 cases. Clin Lung Cancer. 2012;13(4):288–96.CrossRefPubMed Jiang X, Liu Y, Chen C, et al. The value of biomarkers in patients with sarcomatoid carcinoma of the lung: molecular analysis of 33 cases. Clin Lung Cancer. 2012;13(4):288–96.CrossRefPubMed
7.
go back to reference Nishida K, Kobayashi Y, Ishikawa Y, et al. Sarcomatoid adenocarcinoma of the lung: clinicopathological, immunohistochemical and molecular analyses. Anticancer Res. 2002;22(6B):3477–83.PubMed Nishida K, Kobayashi Y, Ishikawa Y, et al. Sarcomatoid adenocarcinoma of the lung: clinicopathological, immunohistochemical and molecular analyses. Anticancer Res. 2002;22(6B):3477–83.PubMed
8.
go back to reference Nakajima M, Kasai T, Hashimoto H, Iwata Y, Manabe H. Sarcomatoid carcinoma of the lung: a clinicopathologic study of 37 cases. Cancer. 1999;86(4):608–16.CrossRefPubMed Nakajima M, Kasai T, Hashimoto H, Iwata Y, Manabe H. Sarcomatoid carcinoma of the lung: a clinicopathologic study of 37 cases. Cancer. 1999;86(4):608–16.CrossRefPubMed
9.
go back to reference Chang YL, Lee YC, Shih JY, Wu CT. Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma. Lung Cancer. 2001;34(1):91–7.CrossRefPubMed Chang YL, Lee YC, Shih JY, Wu CT. Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma. Lung Cancer. 2001;34(1):91–7.CrossRefPubMed
10.
go back to reference Park JS, Lee Y, Han J, et al. Clinicopathologic outcomes of curative resection for sarcomatoid carcinoma of the lung. Oncology. 2011;81(3-4):206–13.CrossRefPubMed Park JS, Lee Y, Han J, et al. Clinicopathologic outcomes of curative resection for sarcomatoid carcinoma of the lung. Oncology. 2011;81(3-4):206–13.CrossRefPubMed
11.
go back to reference Fishback NF, Travis WD, Moran CA, Guinee Jr DG, McCarthy WF, Koss MN. Pleomorphic (spindle/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases. Cancer. 1994;73(12):2936–45.CrossRefPubMed Fishback NF, Travis WD, Moran CA, Guinee Jr DG, McCarthy WF, Koss MN. Pleomorphic (spindle/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases. Cancer. 1994;73(12):2936–45.CrossRefPubMed
12.
go back to reference Yendamuri S, Caty L, Pine M, et al. Outcomes of sarcomatoid carcinoma of the lung: a Surveillance, Epidemiology, and End Results Database analysis. Surgery. 2012;152(3):397–402.CrossRefPubMed Yendamuri S, Caty L, Pine M, et al. Outcomes of sarcomatoid carcinoma of the lung: a Surveillance, Epidemiology, and End Results Database analysis. Surgery. 2012;152(3):397–402.CrossRefPubMed
13.
go back to reference Rossi G, Cavazza A, Sturm N, et al. Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases. Am J Surg Pathol. 2003;27(3):311–24.CrossRefPubMed Rossi G, Cavazza A, Sturm N, et al. Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases. Am J Surg Pathol. 2003;27(3):311–24.CrossRefPubMed
14.
go back to reference Pelosi G, Fraggetta F, Nappi O, et al. Pleomorphic carcinomas of the lung show a selective distribution of gene products involved in cell differentiation, cell cycle control, tumor growth, and tumor cell motility: a clinicopathologic and immunohistochemical study of 31 cases. Am J Surg Pathol. 2003;27(9):1203–15.CrossRefPubMed Pelosi G, Fraggetta F, Nappi O, et al. Pleomorphic carcinomas of the lung show a selective distribution of gene products involved in cell differentiation, cell cycle control, tumor growth, and tumor cell motility: a clinicopathologic and immunohistochemical study of 31 cases. Am J Surg Pathol. 2003;27(9):1203–15.CrossRefPubMed
15.
go back to reference Davis MP, Eagan RT, Weiland LH, Pairolero PC. Carcinosarcoma of the lung: Mayo Clinic experience and response to chemotherapy. Mayo Clin Proc. 1984;59(9):598–603.CrossRefPubMed Davis MP, Eagan RT, Weiland LH, Pairolero PC. Carcinosarcoma of the lung: Mayo Clinic experience and response to chemotherapy. Mayo Clin Proc. 1984;59(9):598–603.CrossRefPubMed
16.
go back to reference Ouziane I, Boutayeb S, Mrabti H, Lalya I, Rimani M, Errihani H. Sarcomatoid carcinoma of the lung: a model of resistance of chemotherapy. N Am J Med Sci. 2014;6(7):342–5.CrossRefPubMedPubMedCentral Ouziane I, Boutayeb S, Mrabti H, Lalya I, Rimani M, Errihani H. Sarcomatoid carcinoma of the lung: a model of resistance of chemotherapy. N Am J Med Sci. 2014;6(7):342–5.CrossRefPubMedPubMedCentral
17.
go back to reference Czerninski R, Zini A, Sgan-Cohen HD. Lip cancer: incidence, trends, histology and survival: 1970-2006. Br J Dermatol. 2010;162(5):1103–9.CrossRefPubMed Czerninski R, Zini A, Sgan-Cohen HD. Lip cancer: incidence, trends, histology and survival: 1970-2006. Br J Dermatol. 2010;162(5):1103–9.CrossRefPubMed
18.
go back to reference Jatti D, Puri G, Aravinda K, Dheer DS. An atypical metastasis of renal clear cell carcinoma to the upper lip: a case report. J Oral Maxillofac Surg. 2015;73(2):371. e1–6.CrossRefPubMed Jatti D, Puri G, Aravinda K, Dheer DS. An atypical metastasis of renal clear cell carcinoma to the upper lip: a case report. J Oral Maxillofac Surg. 2015;73(2):371. e1–6.CrossRefPubMed
19.
go back to reference Hirshberg A, Shnaiderman-Shapiro A, Kaplan I, Berger R. Metastatic tumours to the oral cavity – pathogenesis and analysis of 673 cases. Oral Oncol. 2008;44(8):743–52.CrossRefPubMed Hirshberg A, Shnaiderman-Shapiro A, Kaplan I, Berger R. Metastatic tumours to the oral cavity – pathogenesis and analysis of 673 cases. Oral Oncol. 2008;44(8):743–52.CrossRefPubMed
Metadata
Title
Upper lip metastasis of sarcomatoid carcinoma of the lung – an unusual site of disease: a case report
Authors
Tri Le
Melissa Mayer
Joseph Sailors
David E. Gerber
John M. Truelson
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2017
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-016-1178-y

Other articles of this Issue 1/2017

Journal of Medical Case Reports 1/2017 Go to the issue